Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

420.38 13.12 −3.03%
Market cap
$50.5B
P/E
39.5×
Fwd P/E
42.9×
Dividend yield
0.84%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100

Humana Inc. 10-Q filed Jul 29, 2026

Fiscal Q2 2026 · Period ended Jun 30, 2026 · Filed · accepted 2:11 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Apr 29, 2026: 4 added · 2 removed · 44 modified; 8 with only figures updated

  1. Removed · Value Creation Initiatives

    As a result of these initiatives, we recorded charges of $98 million and $24 million for the three months ended March 31, 2026 and 2025, respectively, within operating costs in the consolidated statements of income. The charges primarily relate to external consulting spend, severance and other employee related charges in connection

49 more changes in this Item, word by word, in Powerpack.

Powerpack